JPMORGAN CHASE & CO - NEVRO CORP ownership

NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 109 filers reported holding NEVRO CORP in Q3 2015. The put-call ratio across all filers is 0.37 and the average weighting 0.5%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of NEVRO CORP
ValueSharesWeighting
Q3 2023$2,269,998
-30.7%
118,106
-8.4%
0.00%
Q2 2023$3,276,766
-28.1%
128,905
+2.2%
0.00%
-100.0%
Q1 2023$4,560,000
+7651.9%
126,124
-91.5%
0.00%
-87.5%
Q4 2022$58,824
-99.9%
1,485,471
-7.1%
0.01%
-27.3%
Q3 2022$74,480,000
+23.4%
1,598,269
+16.1%
0.01%
+37.5%
Q2 2022$60,358,000
-38.9%
1,377,111
+0.8%
0.01%
-33.3%
Q1 2022$98,815,000
+3.6%
1,366,186
+16.1%
0.01%
+9.1%
Q4 2021$95,363,000
-30.3%
1,176,299
+0.1%
0.01%
-35.3%
Q3 2021$136,811,000
-29.6%
1,175,552
+0.3%
0.02%
-26.1%
Q2 2021$194,295,000
+14.7%
1,171,934
-3.5%
0.02%0.0%
Q1 2021$169,374,000
-12.1%
1,214,150
+9.0%
0.02%
-17.9%
Q4 2020$192,765,000
+34.9%
1,113,604
+8.1%
0.03%
+16.7%
Q3 2020$142,936,000
+20.6%
1,030,397
+3.8%
0.02%
+4.3%
Q2 2020$118,560,000
+5.3%
992,382
-11.9%
0.02%
-11.5%
Q1 2020$112,559,000
-11.6%
1,125,810
+3.9%
0.03%
+8.3%
Q4 2019$127,359,000
+16.1%
1,083,536
-15.1%
0.02%
+9.1%
Q3 2019$109,660,000
+27.0%
1,275,556
-4.1%
0.02%
+29.4%
Q2 2019$86,318,000
+12.1%
1,330,638
+8.0%
0.02%
+6.2%
Q1 2019$76,989,000
+88.4%
1,231,615
+17.2%
0.02%
+77.8%
Q4 2018$40,860,000
-31.8%
1,050,660
-0.1%
0.01%
-18.2%
Q3 2018$59,947,000
-17.3%
1,051,674
+15.9%
0.01%
-26.7%
Q2 2018$72,449,000
+0.9%
907,315
+9.5%
0.02%0.0%
Q1 2018$71,797,000
+29.8%
828,400
+3.4%
0.02%
+25.0%
Q4 2017$55,311,000
-13.2%
801,148
+11.8%
0.01%
-14.3%
Q3 2017$63,701,000
+29.2%
716,472
+8.2%
0.01%
+27.3%
Q2 2017$49,302,000
-14.8%
662,390
+7.3%
0.01%
-15.4%
Q1 2017$57,833,000
+21.3%
617,206
-5.9%
0.01%
+18.2%
Q4 2016$47,669,000
-26.5%
656,085
+5.6%
0.01%
-31.2%
Q3 2016$64,859,000
+6.4%
621,308
-24.8%
0.02%
+6.7%
Q2 2016$60,939,000
+27.0%
826,197
-3.1%
0.02%
+25.0%
Q1 2016$47,976,000
-13.6%
852,758
+3.7%
0.01%
-14.3%
Q4 2015$55,497,000
+47.5%
822,063
+1.4%
0.01%
+40.0%
Q3 2015$37,626,000
-14.6%
811,071
-1.0%
0.01%0.0%
Q2 2015$44,047,000
+110.1%
819,479
+87.3%
0.01%
+100.0%
Q1 2015$20,966,000
+49.3%
437,437
+20.4%
0.01%
+66.7%
Q4 2014$14,045,000363,2340.00%
Other shareholders
NEVRO CORP shareholders Q3 2015
NameSharesValueWeighting ↓
BRAIDWELL LP 1,192,298$47,215,0011.58%
Altium Capital Management LP 76,000$3,009,6001.53%
Rock Springs Capital Management LP 1,077,900$42,684,8401.03%
Integral Health Asset Management, LLC 109,000$4,316,4000.91%
ArrowMark Colorado Holdings LLC 1,252,218$49,587,8330.59%
FOX RUN MANAGEMENT, L.L.C. 26,963$1,067,7350.43%
PDT Partners, LLC 55,715$2,206,3140.36%
FRED ALGER MANAGEMENT, LLC 1,184,000$46,886,4000.25%
Dynamic Technology Lab Private Ltd 62,819$2,4880.25%
K2 PRINCIPAL FUND, L.P. 38,000$1,504,8000.23%
View complete list of NEVRO CORP shareholders